.jpg)
.jpg)
Tufts University School of Medicine
1980-81 Fellow, National Kidney Foundation – University of Pennsylvania
1981-84 Resident, University of Pennsylvania – Chairman, Alan Wein, MD
1984-85 Fellow, University of California Los Angeles – Director, Shlomo Raz, MD
1985-89 Faculty, Boston University Medical Center
1989-02 Faculty, Harvard University – Beth Israel Medical Center
2002-08 Faculty, Weill-Cornell Medical College – New York-Presbyterian Hospital
2008- Faculty, Tufts University – St. Elizabeth’s Medical Center
Dr. Staskin has served as a member: HHS Incontinence Guidelines– US Government Guidelines - (panel) / ICI Guidelines for Incontinence - (Chairperson)
AUA Guidelines: “Surgical Management of Stress Urinary Incontinence.” - (panel) / Society for Urodynamics and Female Urology - (past Board of Directors) / American Urogynecological Society (AUGS) - (past Board of Directors) / American Association Clinical Urologists / UROPAC - (past Board of Directors) / AUA Guidelines: “Management of Overactive Bladder” - (reviewer).
Dr. Staskin has published extensively (> 145articles) in the areas of female urology, male voiding dysfunction, BPH and LUTS,
neuro-urology, and urodynamics. He is editor /co-editor of the textbooks - Textbook of Female Urology and Urogynecology 4 editions / Atlas of Bladder Diseases and Interstitial Cystitis 2 editions.
Dr. Staskin has assigned 67 patents and is the inventor of multiple female urology products for stress incontinence and prolapse. He has served as a medical consultant/advisor for multiple pharmaceutical and device companies for commercialized products and those in development. Dr. Staskin is the founder of 3 companies in the biotech arena. (see disclosures)
Disclosure information not submitted.
Sunday, May 15, 2022
8:50 AM – 9:00 AM